A new analysis in Clinical Gastroenterology and Hepatology (Brenner et al., Sept 2025) examines geodemographic trends in private equity (PE) acquisitions of U.S. gastroenterology practices from 2013–2023. The study confirms that GI has become a prime target for PE investment, driven by its high-volume procedures, strong ancillary revenue streams, and outpatient consolidation opportunities. What was once an abstract trend is now local and visible, directly shaping daily GI practice across the country. The findings underscore how PE is reshaping practice ownership and care delivery in gastroenterology.
Trending
- Pfizer’s $10B monthly GLP-1 bet generates competitive weight loss in phase 2b (Fierce Biotech)
- ‘AI-native’ outpatient surgery startup Oath Surgical inks Nvidia partnership (Fierce Biotech)
- NVIDIA, Oath Surgical, ASCs and the Future of Physical AI in Healthcare (LSI | LinkedIn)
- UMass Successfully Performs Its First Full-Thickness Resection Device Procedure (UMass Chan Medical School)
- 5 gastroenterology physician moves in 1 month (Becker’s GI & Endoscopy)
- Artificial Intelligence on Trial: Who’s Liable When Clinical Algorithms Go Wrong? (Medscape)
- Building the Future Gastroenterologist: Why Nutrition and Lifestyle Medicine Must Be Core Competencies (ACG Case Reports Journal)
- Spray Cryotherapy Esophageal Consortium Consensus Recommendations for Liquid Nitrogen Spray Cryotherapy in Barrett’s Esophagus and Esophageal Cancer Using a Modified Delphi Process (The American Journal of Gastroenterology)
